Endotoxin Neutralization as a Biomonitor for Inflammatory Bowel Disease

por Champion, Keith, Chiu, Laura, Ferbas, John, Pepe, Michael
Publicado 2013

The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics

por Sherman, David J., Liu, Lei, Mamrosh, Jennifer L., Xie, Jiansong, Ferbas, John, Lomenick, Brett, Ladinsky, Mark S., Verma, Rati, Rulifson, Ingrid C., Deshaies, Raymond J.
Publicado 2023

Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab

por Jassem, Shea, Wang, Wei, Sweet, Heather, Manoukian, Raffi, Chow, Vincent, Kanakaraj, Palanisamy, Hutterer, Katariina M., Kuhns, Scott, Foltz, Ian N., Chen, Qing, Ferbas, John, McBride, Helen J.
Publicado 2019

Treatment of systemic lupus erythematosus patients with the BAFF antagonist “peptibody” blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b tria...

por Stohl, William, Merrill, Joan T., Looney, R. John, Buyon, Jill, Wallace, Daniel J., Weisman, Michael H., Ginzler, Ellen M., Cooke, Blaire, Holloway, Donna, Kaliyaperumal, Arunan, Kuchimanchi, Kameswara Rao, Cheah, Tsui Chern, Rasmussen, Erik, Ferbas, John, Belouski, Shelley S., Tsuji, Wayne, Zack, Debra J.
Publicado 2015